Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Ionis Pharmaceuticals Inc., 3 years.
Ionis Pharmaceuticals Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Ionis Pharmaceuticals Inc. June 5, 202597.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 7, 2026 | Ionis Pharmaceuticals Inc. | Option exercise | +10,111 | $47.11 | $476,329 |
| Jul 7, 2026 | Ionis Pharmaceuticals Inc. | Open-market sale | −10,111 | $85.42 | $863,637 |
| Mar 3, 2026 | Ionis Pharmaceuticals Inc. | Option exercise | +10,321 | $41.08 | $423,987 |
| Mar 3, 2026 | Ionis Pharmaceuticals Inc. | Option exercise | +12,000 | $38.06 | $456,720 |
| Mar 3, 2026 | Ionis Pharmaceuticals Inc. | Option exercise | +18,000 | $40.05 | $720,900 |
| Mar 3, 2026 | Ionis Pharmaceuticals Inc. | Open-market sale | −39,265 | $79.11 | $3,106,254 |
| Mar 3, 2026 | Ionis Pharmaceuticals Inc. | Open-market sale | −14,608 | $79.88 | $1,166,887 |
| Mar 3, 2026 | Ionis Pharmaceuticals Inc. | Open-market sale | −1,005 | $80.80 | $81,204 |
| Aug 22, 2025 | Ionis Pharmaceuticals Inc. | Open-market sale | −1,427 | $42.53 | $60,690 |
| Jul 15, 2025 | Ionis Pharmaceuticals Inc. | Option exercise | +4,079 | — | — |
| Jul 16, 2024 | Ionis Pharmaceuticals Inc. | Open-market sale | −900 | $48.94 | $44,046 |
| Jul 16, 2024 | Ionis Pharmaceuticals Inc. | Open-market sale | −737 | $50.17 | $36,975 |
| Jul 15, 2024 | Ionis Pharmaceuticals Inc. | Option exercise | +4,677 | — | — |
| Aug 1, 2023 | Ionis Pharmaceuticals Inc. | Open-market sale | −657 | $41.05 | $26,970 |
| Jul 17, 2023 | Ionis Pharmaceuticals Inc. | Option exercise | +5,333 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.